Scientists from IBM, Cleveland Clinic, and RIKEN have used quantum-centric supercomputing to simulate a protein complex with over 12,600 atoms, the largest such simulation on quantum hardware to date. This breakthrough, achieved by combining quantum and classical supercomputers with a novel algorithm, marks a significant step toward using quantum computing to solve complex biological problems, including drug discovery. The improved accuracy and scale could shorten drug development timelines by better predicting drug-protein interactions. This milestone demonstrates quantum computing's emerging practical role in life sciences and chemistry research.
Recent U.S. economic data shows cooling inflation and resilient consumer spending, easing concerns and shifting Wall Street's focus to Q2 earnings from major tech companies like Alphabet, Tesla, and IBM. These earnings will provide insight into AI sp...
Bragar Eagel & Squire, P.C. is investigating IBM for potential securities law violations following the company's Q2 2026 earnings report. IBM missed analyst expectations due to weakness in software and infrastructure, with a shift in customer budgets...
IBM CEO Arvind Krishna stated that just 2% of IBM's software could be replaced by AI-built applications, aiming to reassure investors after disappointing Q2 results. The company faced a decline in mainframe-related software revenue as customers shift...
PatentVest's latest report analyzes OpenAI's 69 published patent families, showing the company's strategic shift from conversational AI to broader AI applications including generative media, AI agents, and developer infrastructure. This portfolio ref...
IBM reported Q2 adjusted earnings per share of $2.93 and revenue of $17.16 billion, both below analyst expectations. The company lowered its full-year constant currency revenue growth forecast to 4-5%, down from the previous outlook, but maintained i...
